Pengcheng Li
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 2
-
- RNA Research and Splicing 5
- RNA modifications and cancer 4
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 2
- Cancer-related gene regulation 2
- Co-authors
- Huifang LiangJie MoJin ChenSu ChenBixiang ZhangYueyang ZhangWei ZhaoYong Wang
- Journals
- Oncogene (1 paper)Biochemical and Biophysical Research Communications (1 paper)Kidney International (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Pengcheng Li
20 papers receiving 476 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 194
- Biological Psychiatry 21
- Molecular Biology 359
- Biochemistry 20
- Immunology 43
Countries citing papers authored by Pengcheng Li
This map shows the geographic impact of Pengcheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Li more than expected).
Fields of papers citing papers by Pengcheng Li
This network shows the impact of papers produced by Pengcheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Li. The network helps show where Pengcheng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengcheng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 148 | |
| 14 | 2021 | 28 | |
| 15 | 2019 | 30 | |
| 16 | 2018 | 33 | |
| 17 | 2017 | 111 | |
| 18 | The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo. | 2016 | 43 |
| 19 | 2012 | 6 | |
| 20 | 2006 | 10 |
About Pengcheng Li
Pengcheng Li is a scholar working on Cancer Research, Biological Psychiatry and Behavioral Neuroscience, having authored 23 papers that have together received 478 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (2 papers), Ubiquitin and proteasome pathways (2 papers), Cancer-related gene regulation (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (194 citations), Biological Psychiatry (21 citations) and Molecular Biology (359 citations). Pengcheng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Huifang Liang, Jie Mo, Jin Chen, Su Chen, Bixiang Zhang, Yueyang Zhang, Wei Zhao, Yong Wang, Xiandong Zeng and Weiguo Zhang. Their work appears in journals such as Oncogene, Biochemical and Biophysical Research Communications and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.